Back to VANGUARD GROUP INC

PTGX
6 quarters

Position history for VANGUARD GROUP INC's holdings in PROTAGONIST THERAPEUTICS INC

VANGUARD GROUP INC holds 5.4M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $472.8M as of 2025-Q4. The position was increased (+27.2% shares). PTGX represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$472.8M

Current Shares

5.4M

Total Value Change

+$283.1M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
5.4M
+27.2%
$472.8M0.0%$87.26
39
2025-Q3
Decreased
4.3M
-2.3%
$282.8M0.0%$65.14
0
2025-Q2
Increased
4.4M
+1.9%
$240.9M0.0%$55.69
31
2025-Q1
Increased
4.3M
+1.4%
$206.8M0.0%$48.88
31
2024-Q4
Increased
4.2M
+0.1%
$162.9M0.0%$38.51
30
2024-Q3
New
4.2M
-
$189.7M0.0%$44.56
42

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C., UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used